Research & Development: Page 59
-
PharmaVoice Team/PharmaVoice
What's New
What’s New The clinical research organization, PharmaNet/i3, has been renamed inVentiv Health Clinical. This renaming reflects the closer alignment between the clinical segment and inVentiv’s commercial and consulting services. “As a global contract research organization, renaming ourselves inVen...
By Ann Grey • March 28, 2013 -
PharmaVoice Team/PharmaVoice
UpFront
» Lilly Recognized for Fifth Straight Year by NAFE Lilly has been named to the NAFE Top 50 Companies for Executive Women list for 2013. Compiled by the National Association for Female Executives (NAFE), the list recognizes organizations whose policies and practices encourage women’s advancemen...
By Denise Myshko • March 28, 2013 -
Explore the Trendline➔
Stock via Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Disrupting the Model: Patient-Centricity
Disrupting the Model: Patient-Centricity The industry may be on the verge of a dramatic change in operations to address the growing move toward putting patients at the center of, well, everything. By Robin Robinson Industry analysts have been reporting on the need for industry transformation towa...
By Robin Robinson • Feb. 27, 2013 -
PharmaVoice Team/PharmaVoice
Genomic Innovation
Our understanding of disease and biology is growing every day, giving researchers even more power to develop new and better medicines. The area of genetics is taking off, industry experts say. The ability to sequence individual genomes and the genomes of diseases is providing new avenues of resea...
By Denise Myshko • Feb. 27, 2013 -
PharmaVoice Team/PharmaVoice
Courageous Leadership
Courageous Leadership By Robin Robinson To navigate through disruptive change, the industry’s leaders need to be open, strong, and have the willingness to try something new. In its From Vision to Decision 2020 report, PricewaterhouseCoopers (PwC) analysts say successful innovation requires strong...
By Robin Robinson • Feb. 27, 2013 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma Pool Randy MILBY Dr. Antony PFAFFLE CorMedix Announces Changes in Executive Team CorMedix, a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardio renal disease, has made changes to its executive team. Randy Milb...
By Ann Grey • Feb. 27, 2013 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Developers Need to Identify Causes of R&D Inefficiency E-Prescribing Market Expected to Grow Up Front Planning is Key for Oncology Trials MHealth Market to Experience Growth Outlook for 2013 Life Sciences Industry Dr...
By Denise Myshko • Feb. 27, 2013 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
Trinity Pharma Introduces Real-Time Mobile Analytics Solution Trending Now: Mobile solutions have created an opportunity to rethink the way information is consumed and delivered. Trinity Pharma has released AgileM, a mobile analytics platform designed specifically for life-sciences companies. Cou...
By Denise Myshko • Feb. 27, 2013 -
PharmaVoice Team/PharmaVoice
Clinical Nurse Educators: Driving Diagnosis, Prescribing, and Adherence
Clinical Nurse Educators: Driving Diagnosis, Prescribing, and Adherence Pete Megronigle, VP, Head of Health Management Solutions, Quintiles Faced by a broad array of challenges — from healthcare reforms to evolving practice dynamics — physicians have little time to spend with patients, and still...
By Pete Megronigle • Jan. 28, 2013 -
PharmaVoice Team/PharmaVoice
Medical Affairs Outsourcing
Medical Affairs Outsourcing What are the top trends/reasons that have impacted the discipline of medical affairs and its function within the biopharmaceutical, medical device, and diagnostics industries and why is outsourcing of this function so desirable? The medical affairs function is increasi...
By Beth Price • Jan. 28, 2013 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Outsourcing: Outsourcing For Efficiency
Outsourcing for Efficiency For many sponsor companies in the life-sciences industry engaging with outsourcing partners — from the clinic to the market — is imperative if they want to drive efficiencies in time, money, and personnel as well as innovation. Life-sciences companies can reap the many ...
By Taren Grom • Jan. 28, 2013 -
PharmaVoice Team/PharmaVoice
C-Suite: Specialty Pharma
Specialty Pharma Targeted Opportunities C-Suite: Specialty Pharma By Taren Grom The growing U.S. specialty pharmaceuticals market is comprised of more than 90 companies marketing more than 550 prescription pharmaceutical products, according to MCD Group, and dozens of therapeutic categories, incl...
By Taren Grom • Jan. 28, 2013 -
PharmaVoice Team/PharmaVoice
Saudi Arabia: Oil Wealth Opens Doors to Health and Life Sciences
Saudi Arabia: Oil Wealth Opens Doors to Health and Life Sciences By Kim Ribbink Its wealth, growing population, investment in health and the life sciences, and high rates of diseases such as diabetes, make Saudi Arabia an exciting market for pharma companies. Saudi Arabia is perhaps best known fo...
By Kim Ribbink • Jan. 28, 2013 -
PharmaVoice Team/PharmaVoice
Compliance with GCP
Compliance with GCP With more clinical trials being done outside the United States and an increased focus by regulators on patient safety, it’s critical for pharma companies to follow good clinical practices in their development programs. By Denise Myshko Regulators around the globe are requiring...
By Denise Myshko • Jan. 28, 2013 -
PharmaVoice Team/PharmaVoice
The Cloud in Pharma Research
The Cloud in Pharma Research The cloud has the potential to bring more efficient data management to clinical research, but pharmaceutical companies are approaching source sharing cautiously. Web-based solutions for R&D are not new, but during the past few years, they have morphed into what m...
By Denise Myshko • Jan. 28, 2013 -
PharmaVoice Team/PharmaVoice
Last Word
Focus: Oncology Paul Hawthorne, VP and Head, Oncology Business Unit at Sanofi US Inc., talks about how the company is addressing unmet needs in cancer. At Sanofi Oncology the aim is to combat cancer in all its different forms by carrying out research on the different pathways involved in the dev...
By Paul Hawthorne • Jan. 25, 2013 -
PharmaVoice Team/PharmaVoice
Talent Pool
Biotech Pool Dr. Michelle BERREY Chimerix Appoints CMO Chimerix, a biotechnology company developing orally available antiviral therapeutics, has named Michelle Berrey, M.D., chief medical officer. Before joining Chimerix, Dr. Berrey was chief medical officer at Pharmasset. Lindsay ROCCO Dendreon ...
By Taren Grom • Jan. 25, 2013 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Formulary Decision Makers Want Digital Resources from Pharma Companies Lose Revenue to Nonadherence Contract Sales to Grow KOL Advocacy is Critical Sidebar: Nonadherence Study Highlights Thought Leader Pool Shrinking as ...
By Taren Grom • Jan. 25, 2013 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
New electronic and web-based applications, sites, and technologies Trending Now: As trials become larger and more complex, enhancing efficiency and traceability of clinical trial inventory is critical. PharmaVigilant has released I-Accountability, a drug accountability system that efficiently tra...
By Taren Grom • Jan. 25, 2013 -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies Featured Briefs: Publicis Healthcare Communications Group Launches Publicis Health Media Havas Health Launches New Global Agency Group INC Research Expands Global Consulting Capabilities Cenduit Introduces New Clinical Trial Supply Simulati...
By Taren Grom • Jan. 25, 2013 -
PharmaVoice Team/PharmaVoice
CHILE: Opportunities and Challenges
Chile is considered to be Latin America’s economic powerhouse, but it is a forgotten paradise some say because it is the most politically and economically stable country in Latin America and doesn’t generate the headlines of some of its neighbors. The Pharmaceutical Landscape Geographically ancho...
By Taren Grom • Dec. 27, 2012 -
PharmaVoice Team/PharmaVoice
ACOs: A New Health Model for a New World
How healthcare is delivered to Medicare patients is changing as a result of the Affordable Care Act (ACA) of 2010. Accountable care organizations (ACOs) are groups of providers that aim to provide integrated and coordinated care to Medicare patients that is driven by outcomes, and, if successful,...
By Denise Myshko • Dec. 27, 2012 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Soft Metrics Uncover Medical Publications’ True Value Use of Efficacy and Effectiveness May Skew Reimbursement Decisions Extraneous Data Collected in Clinical Trials Cost Drug Developers Leading Biosimilar Companies Expe...
By Denise Myshko • Dec. 27, 2012 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: Symphony Health Solutions Launches ePrescribing Solutions Suite Optum Accelerates Late-Phase Research E-UPGRADES AND ENHANCEMENTS In other technology news Source Healthcare Analytics, a Symphony Health Solutions c...
By Denise Myshko • Dec. 27, 2012 -
PharmaVoice Team/PharmaVoice
Experts: Thought Leaders
Mike Ackermann, Ph.D. Senior VP, Global Commercial Solutions, Quintiles, a biopharmaceutical services company offering fully integrated clinical, commercial, consulting, and capital solutions. For more information, visit quintiles.com. Faraz Ali. VP, Program Management and Commercial Planning, b...
By PharmaVoice Team • Nov. 13, 2012
Previous
